These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 7992211

  • 1. [The effect of thrombolytic therapy with the preparation APSAC on the course of myocardial infarct].
    Urazgil'deeva SA, Aminieva KhK, Varshavskiĭ SIu.
    Ter Arkh; 1994; 66(9):41-5. PubMed ID: 7992211
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Thrombolysis with intravenous APSAC in patients with acute myocardial infarction].
    Ribeiro E, Silva LA, Petrizzo A, Torossian SP, Oliveira JL, Buffollo E, Duprat Filho R.
    Arq Bras Cardiol; 1991 Jul; 57(1):5-8. PubMed ID: 1823762
    [Abstract] [Full Text] [Related]

  • 4. [Thrombolytic therapy in acute myocardial infarct--is it being used to the fullest?].
    Carôla B, Calçada-Correia L, Pedro PG, Conduto R, Dionísio I, Fiuza M, Dias E, Vaz Carneiro A, Amador MG, de Pádua F, Lopes MG.
    Rev Port Cardiol; 1996 Dec; 15(12):867-76, 863. PubMed ID: 9052962
    [Abstract] [Full Text] [Related]

  • 5. Eligibility of patients with acute myocardial infarction for thrombolytic therapy: retrospective cohort study.
    Zaputović L, Mavrić Z, Mlinarić B, Kupanovac Z, Matana A, Marinović D.
    Croat Med J; 2000 Dec; 41(4):401-5. PubMed ID: 11063763
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
    Sakai M, Imai T, Kuboki K, Maeda S, Ueda S, Kuwajima I, Ohkawa S, Matsushita S.
    J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
    [Abstract] [Full Text] [Related]

  • 10. Very early thrombolysis in acute myocardial infarction--a light at the end of the tunnel.
    Rozenman Y, Gotsman M, Weiss T, Lotan C, Mosseri M, Sapoznikov D, Welber S, Nassar H, Hasin Y, Gilon D.
    Isr J Med Sci; 1994 Jan; 30(1):99-107. PubMed ID: 8138401
    [Abstract] [Full Text] [Related]

  • 11. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
    Hadi HA, Al Suwaidi J, Bener A, Khinji A, Al Binali HA.
    Int J Cardiol; 2005 Jul 10; 102(2):249-54. PubMed ID: 15982492
    [Abstract] [Full Text] [Related]

  • 12. Multicenter clinical trial of thrombolytic therapy in 1,406 patients with acute myocardial infarction. Collaborative Group of Clinical Trial for Urokinase Therapy.
    Hu D, Xu Z.
    Chin Med J (Engl); 1997 Nov 10; 110(11):839-42. PubMed ID: 9772414
    [Abstract] [Full Text] [Related]

  • 13. [Planar myocardial scintigraphy with 99mTc sestamibi for the evaluation of the infarct area and the efficacy of the thrombolytic therapy].
    Paventi S, Parafati MA, Di Luzio E, Pellegrino CA.
    Minerva Cardioangiol; 1999 Mar 10; 47(3):59-64. PubMed ID: 10389445
    [Abstract] [Full Text] [Related]

  • 14. [The adult respiratory distress syndrome as a complication of the APSAC treatment of acute myocardial infarct. Apropos a case].
    García González MJ, Bosa Ojeda F, Barragán Acea A, Marrero Rodríguez F, Laynez Cerdeña I, Lara Padrón A, Lacalzada Almeida J, de Armas Trujillo D.
    Rev Esp Cardiol; 1993 Oct 10; 46(10):674-6. PubMed ID: 8235004
    [Abstract] [Full Text] [Related]

  • 15. [Death after ST-elevation myocardial infarction in patients treated with fibrinolytic therapy, angioplasty, or conventional therapy. A post-mortem study to verify cardiac rupture as a cause of death].
    Fornaro G, Lazzero M, Giacalone A, Aralda D, Prando MD, Rossi L, Bongo AS.
    G Ital Cardiol (Rome); 2008 Jun 10; 9(6):408-20. PubMed ID: 18681392
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Thrombolytic therapy for myocardial infarction facilitated by mobile coronary care.
    Wilson C, O'Mullan S, Moore M, McCarthy M.
    Ulster Med J; 2004 Nov 10; 73(2):77-84. PubMed ID: 15651765
    [Abstract] [Full Text] [Related]

  • 18. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
    Berrocal DH, Cohen MG, Spinetta AD, Ben MG, Rojas Matas CA, Gabay JM, Magni JM, Nogareda G, Oberti P, Von Schulz C, Doval H, Bazzino OO, Cagide A, Oliveri R, Grinfeld LR.
    Am Heart J; 2003 Dec 10; 146(6):E22. PubMed ID: 14661011
    [Abstract] [Full Text] [Related]

  • 19. Effects of patency of infarct-related coronary artery on acute outcome in acute myocardial infarction patients undergoing urokinase therapy. Collaborative Research Group on Thrombolysis.
    Chin Med J (Engl); 1997 Mar 10; 110(3):187-90. PubMed ID: 9594337
    [Abstract] [Full Text] [Related]

  • 20. [Clinical analysis of early stage thrombolytic therapy with venous urokinase for acute myocardial infarction in 24 cases].
    Zhi SQ.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov 10; 25(11):1452-3. PubMed ID: 16305979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.